FindTrial
Sign In

GP

DRUG6 trials

Sponsors

National Cancer Center, Korea, Sun Yat-sen University, Changhai Hospital, Hospital de Clinicas de Porto Alegre, Guangxi Medical University

Conditions

Bariatric Surgery CandidateLocally Advanced and Metastatic Pancreatic CancerNasopharyngeal CarcinomaNeoadjuvant TherapyNon Small Cell Lung CancerObesity, MorbidPD-1 InhibitorRecurrent Nasopharyngeal Carcinoma

Phase 1

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
NCT04324307
Changhai HospitalLocally Advanced and Metastatic Pancreatic Cancer
Start: 2019-11-26End: 2023-11-30Target: 60Updated: 2023-09-01

Phase 2

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
CompletedNCT01003964
National Cancer Center, KoreaNon Small Cell Lung Cancer
Start: 2009-02-28End: 2015-06-30Updated: 2022-04-12
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Active, not recruitingNCT05340270
Guangxi Medical UniversityNasopharyngeal Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor
Start: 2022-07-15End: 2029-03-29Updated: 2025-12-11
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma
RecruitingNCT06455410
Sun Yat-sen UniversityNasopharyngeal Carcinoma
Start: 2024-06-18End: 2028-06-18Target: 216Updated: 2024-06-25

Phase 3

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
RecruitingNCT03907826
Sun Yat-sen UniversityRecurrent Nasopharyngeal Carcinoma
Start: 2020-03-01End: 2028-12-31Target: 212Updated: 2025-01-28

Unknown Phase

Prophylactic Use of Noninvasive Ventilation in the Postoperative Period of Bariatric Surgery
CompletedNCT04805476
Hospital de Clinicas de Porto AlegreBariatric Surgery Candidate, Obesity, Morbid, Ventilatory Failure
Start: 2017-03-01End: 2018-07-31Updated: 2021-03-18

Related Papers

Induction chemotherapy with or without toripalimab followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter, open-label, randomized, controlled, phase 2 trial.
Journal of Clinical Oncology2025-05-28
A multicenter, randomized, double-blind phase III clinical study to evaluate the efficacy and safety of KN046 combined with nab-paclitaxel and gemcitabine versus placebo combined with nab-paclitaxel and gemcitabine in patients with advanced pancreatic cancer (ENREACH-PDAC-01).
Journal of Clinical Oncology2022-06-019 citations
A phase II study of KN046 monotherapy as 2<sup>nd</sup> line and above treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
Journal of Clinical Oncology2022-06-015 citations
Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
Journal of Clinical Oncology2021-05-2013 citations
PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
2016-08-1231 citations